Market Place
Sourcing Support
Jubilant`s Generics Solifenacin Receives Tentative Approval in US
02 Oct 2024 //
FDA
Lannett`s Generic Solifenacin Succinate Receives Approval in the U.S.
06 Jun 2023 //
FDA
Aurobindo`s Generic Sildenafil Citrate Receives Approval in the U.S.
27 Dec 2022 //
FDA
Annora Pharma`s Generic Solifenacin Succinate Receives Approval in the U.S.
15 Jun 2022 //
FDA
Cipla recalls 7,228 bottles of overactive bladder treatment drug in America
25 Jul 2021 //
ECONOMIC TIMES
Enforcement Report - Week of July 21, 2021
21 Jul 2021 //
FDA
Zydus Cadila receives USFDA final approval for Solifenacin Succinate Tablets
20 Oct 2020 //
BUSINESS-STANDARD
Zydus Cadila gets USFDA nod for overactive bladder treatment drug
19 Oct 2020 //
ECONOMICTIMES
FDA Approves VESIcare LS™ Oral Suspension for Pediatric Patients
27 May 2020 //
PRNEWSWIRE
FDA Approves 1st Treatment for a Form of Bladder Dysfunction Pediatric Patients
26 May 2020 //
PR NEWSWIRE
Sunshine Lake Generic Solifenacin Succinate Receives Approval in US
15 Apr 2020 //
FDA
Enforcement Report - Week of March 25, 2020
25 Mar 2020 //
FDA
CSPC Ouyi Pharm Co`s Generic Solifenacin Succinate Receives Approval in US
13 Dec 2019 //
FDA
CSPC Ouyi Pharm Co`s Generic Solifenacin Succinate Receives Approval in US
12 Dec 2019 //
FDA
Strides Pharma Science arm gets USFDA nod for drug to treat overactive bladder
27 Sep 2019 //
THE ECONOMIC TIMES
Strides Pharma suspends sale of Ranitidine tab in US
27 Sep 2019 //
THE ECONOMIC TIMES
Unichem Labs Generic Solifenacin Succinate Receives Approval in US
29 Aug 2019 //
FDA
Alembic Pharma gets USFDA nod for overactive bladder treatment drug
21 May 2019 //
MONEYCONTROL
Glenmark Pharma gets USFDA nod for overactive bladder treatment drug
21 May 2019 //
MONEYCONTROL
Orchid Pharma says closer to resolution as RP has received three plans
20 May 2019 //
BUSINESS-STANDARD
Glenmark Pharma gets USFDA nod for overactive bladder treatment drug
20 May 2019 //
MONEYCONTROL
Qilu Pharm`s Generic Solifenacin Succinate Receives Tentative Approval in US
21 Dec 2018 //
FDA
MSN Labs` Generic Solifenacin Succinate Receives Tentative Approval in US
18 Sep 2018 //
FDA
Vesicare® (Solifenacin Succinate) : Astellas Pharma Inc. v. Aurobindo Pharma
25 Jun 2018 //
PATENT LITIGATION
VESIcare® (Solifenacin): Astellas Pharma Inc v. Cipla
05 Jun 2018 //
PATENT LITIGATION
Prescription med: registration of new generics & biosimilars
05 Jun 2018 //
TGA GOV
FDA Approves Supplemental NDA for Myrbetriq® (mirabegron)
07 May 2018 //
PR NEWSWIRE
U.S. FDA Accepts for Review Astellas` Supplemental NDA for mirabegron
12 Sep 2017 //
PR NEWSWIRE
Ajanta Pharma`s Generic Solifenacin Succinate Approval In US
19 Aug 2017 //
FDA
Astellas Submits Supplemental NDA for Mirabegron for Use in Combination
29 Jun 2017 //
PR NEWSWIRE
Glenmark Pharm’s Generic Solifenacin Succinate Receives Tentative
21 Jun 2017 //
FDA
Astellas and Gedeon named for ABPI Code breaches
08 Jun 2017 //
PHARMA TIMES
Allergan chases high-dose, low side effects Alzheimer’s combo in biotech buy
23 Nov 2016 //
FIERCE BIOTECH
Sandoz introduces solifenacin succinate in Canadian market…
10 Oct 2015 //
PHARMABIZ
Myelin-Maker: How an FDA-Approved Drug Boosts Myelin Synthesis
05 Mar 2015 //
EUREKALERT
